HELX vs. FHLC
HELX (Franklin Genomic Advancements ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both Health & Biotech Equities funds. HELX is actively managed, while FHLC is passively managed. Over the past 5 years, HELX returned -3.93%/yr vs 5.11%/yr for FHLC. A 0.72 correlation means they provide meaningful diversification when combined. HELX charges 0.50%/yr vs 0.08%/yr for FHLC.
Performance
HELX vs. FHLC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a -1.55% return, which is significantly lower than FHLC's -1.05% return.
HELX
- 1D
- 3.11%
- 1M
- 5.81%
- YTD
- -1.55%
- 6M
- -4.90%
- 1Y
- 33.84%
- 3Y*
- 5.75%
- 5Y*
- -3.93%
- 10Y*
- —
FHLC
- 1D
- 2.97%
- 1M
- 4.17%
- YTD
- -1.05%
- 6M
- -0.68%
- 1Y
- 17.55%
- 3Y*
- 7.06%
- 5Y*
- 5.11%
- 10Y*
- 9.40%
HELX vs. FHLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | -1.55% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
FHLC Fidelity MSCI Health Care Index ETF | -1.05% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 27.74% |
Correlation
The correlation between HELX and FHLC is 0.70, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.73 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.75 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.72 |
The correlation between HELX and FHLC has been stable across timeframes, ranging from 0.70 to 0.75 - a consistent structural relationship.
HELX vs. FHLC - Sectors Allocation Comparison
Sectors
HELX
FHLC
Healthcare
Basic Materials
-
Technology
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Utilities
-
-
Healthcare
HELX
FHLC
Basic Materials
HELX
FHLC
-
Technology
HELX
FHLC
Communication Services
HELX
-
FHLC
-
Consumer Cyclical
HELX
-
FHLC
-
Consumer Defensive
HELX
-
FHLC
-
Energy
HELX
-
FHLC
-
Financial Services
HELX
-
FHLC
Industrials
HELX
-
FHLC
Real Estate
HELX
-
FHLC
-
Utilities
HELX
-
FHLC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. FHLC — Risk / Return Rank
HELX
FHLC
HELX vs. FHLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELX | FHLC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.41 | ||
| Sortino ratioReturn per unit of downside risk | +0.45 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.21 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 1.89 | 1.70 | +0.19 |
| Martin ratioReturn relative to average drawdown | 4.88 | 4.27 | +0.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELX | FHLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.61 | 1.21 | +0.41 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.34 | -0.51 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.56 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.62 | -0.37 |
Drawdowns
HELX vs. FHLC - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for HELX and FHLC.
Loading charts...
Drawdown Indicators
| HELX | FHLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -28.76% | -29.99% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -10.38% | -7.63% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -16.87% | -12.61% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -17.73% | -41.02% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.76% | — |
Current DrawdownCurrent decline from peak | -38.22% | -4.20% | -34.02% |
Average DrawdownAverage peak-to-trough decline | -34.32% | -5.19% | -29.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.95% | 4.12% | +2.83% |
Volatility
HELX vs. FHLC - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) has a higher volatility of 7.45% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 4.95%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | FHLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.45% | 4.95% | +2.50% |
Volatility (6M)Calculated over the trailing 6-month period | 16.47% | 10.52% | +5.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.07% | 14.62% | +6.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.15% | 15.02% | +9.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.41% | 16.84% | +10.57% |
HELX vs. FHLC - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is higher than FHLC's 0.08% expense ratio.
Dividends
HELX vs. FHLC - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.40%, less than FHLC's 1.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | 1.38% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
HELX Franklin Genomic Advancements ETF | 0.40% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HELX and FHLC have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (7.45%) compared to FHLC (4.95%). In terms of maximum drawdown, HELX dropped -58.75% vs FHLC's -28.76%.
On 5-year performance, FHLC leads with 5.11% vs -3.93% for HELX. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.95%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FHLC has performed better with a 5.11% return vs -3.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.50% for HELX.
FHLC has the higher dividend yield at 1.38%, compared with 0.40% for HELX.
They also come from different issuers: Franklin Templeton and Fidelity. Their fees differ too: 0.50% for HELX and 0.08% for FHLC.
HELX currently has the higher Sharpe Ratio (1.61 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and FHLC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer